Successful infliximab therapy for a duodenal stricture caused by Crohn's disease

Inflammatory Bowel Diseases

Volumn 11, Issue 12, 2005, Pages 1123-1125

  Knapp, Albert B ^a   Mirsky, Felice J ^a   Dillon, Evan H ^a   Korelitz, Burton I ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; INFLIXIMAB; LANSOPRAZOLE; MESALAZINE; METOCLOPRAMIDE; METRONIDAZOLE; PANTOPRAZOLE; PREDNISONE; VALGANCICLOVIR;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; DIAGNOSTIC IMAGING; DUODENUM DISEASE; DUODENUM STRICTURE; FEMALE; HUMAN; LABORATORY TEST; LETTER; PRIORITY JOURNAL; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME;

EID: 27944440461     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000191612.43584.94     Document Type: Letter

References (10)

1. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N Engl J Med. 1997;337:1029.
2. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patient with Crohn's disease. N Engl J Med. 1999;340:1398.
3. Hanauer SB, Feagan BG, Lichenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT 1 randomized trial. Lancet. 2002;359:1541.
4. Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med. 1980;302:981-987.
5. Nugent FW, Richmond M, Park SK. Crohn's disease of the duodenum. Gut. 1977;18:115-120.
6. Parsi MA, Achar JP, Richardson S, et al. Predictors of response to infliximab in patients with Crohn's disease. Gastroenterology. 2002;123:707.
7. Lichtenstein GR, Stein R, Lewis JD, et al. The presence of intestinal strictures as associated with poorer responses for active fistulizing Crohn's disease. Am J Gastroenterol. 1999;94:2676.
8. Toy LS, Abittan C, Kornbluth A, et al. Complete bowel obstruction following initial response to infliximab therapy for Crohn's disease: a series of a newly described complication. Gastroenterology. 2000;118:A569.
9. Van Assche G, Geboes K, Rutgeerts P. Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis. 2004;10:55-60.
10. DiSabatino A, Ciccocioppo R, Benazzato L, et al. Infliximab down-regulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients. Aliment Pharmacol Ther. 2004;19:1019-1024.